Table 1.

HCMV monitoring of patients with neurological disorders other than HCMV encephalitis

DiagnosisAnti-HCMV IgG in serumaNo. of patientsNo. of patients positive/no. of patients examined
CSF HCMV PCRAntigenemiabPBL HCMV PCR
Meningitis or+30/31/23/3
 encephalitis 10/10/10/1
Autoimmunologic+50/50/31/4
 CNS diseases30/31/31/3
Cerebrovasular+20/20/10/1
 disorders10/1ND0/1
Idiopathic facial-+10/10/10/1
 nerve palsy20/20/10/2
Sporadic essential11/11/11/1
 myoclonia
Dengerative CNS+10/10/10/1
 diseases10/10/10/1
Peripheral nervous+30/30/31/3
 system or70/71/62/7
 muscle disorders
Tension headache+21/20/12/2
 or psychogenic20/20/10/1
 Totalc 352/354/2611/32
  • a No anti-HCMV IgM antibodies were found.

  • b Detection of HCMV pp65 antigen in PBL by centrifugation culture or by immunocytological testing with the CMV-vue kit (INCSTAR). ND, not determined.

  • c The percentages of patients found to be positive by CSF PCR, for antigenemia, and by PBL PCR were 6, 15, and 34%, respectively.